Author:
Haseeb Abid,Broyles Heather V.,Rashad Ramy,Saeed Hajirah N.
Publisher
Springer International Publishing
Reference105 articles.
1. Scelfo C, ElSheikh RH, Shamim MM, Abbasian J, Ghaffarieh A, Elhusseiny AM. Ocular surface disease in glaucoma patients. Curr Eye Res. 2023;48:219.
2. Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens. 2019;45(1):11–8.
3. Aguayo Bonniard A, Yeung JY, Chan CC, Birt CM. Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opin Drug Metab Toxicol. 2016;12(11):1279–89.
4. Actis AG, Rolle T. Ocular surface alterations and topical antiglaucomatous therapy: a review. Open Ophthalmol J. 2014;8:67–72.
5. Haseeb A, Solyman O, Abd Elfattah D, Sadik N, Elwehidy A, Chauhan MZ, et al. Ocular surface disease in childhood glaucoma. AAPOS. 2023.